Le Lézard
Classified in: Health, Covid-19 virus
Subject: CPG

COVID-19 Pandemic - The government presents its daily update


QUÉBEC CITY, March 23, 2023 /CNW/ - The most recent data on the evolution of COVID-19, in the last 24 hours, in Québec show:

NOTE: As death removals are not shown in the data above, the number of death additions may exceed the number of new deaths for the day.

*Note that the number of cases listed is not representative of the situation since access to screening centres is restricted to priority clienteles.

Vaccination

To follow the evolution of the data on a daily basis, consult the open data or
the INSPQ website at https://www.donneesquebec.ca/recherche/fr/organization/msss or at https://www.inspq.qc.ca/covid-19/donnees. Note that certain data, especially the number of cases, deaths and doses administered, may be subject to daily readjustment for previous days, given that a catch-up is necessary due to a delay in data entry.

A reminder concerning public health instructions:

To limit the spread of the coronavirus as much as possible, it is important to follow basic preventive measures such as hand washing, physical distancing, wearing a face covering and following the instructions in effect.

Remember that in the event of symptoms, it is always essential to isolate yourself and consult one of the self-care guides or call 1-877-644-4545 (or the telephone code corresponding to the region concerned) to find out the measures to be taken.

Related links:

SOURCE Ministère de la Santé et des Services sociaux


These press releases may also interest you

at 14:20
GRAIL, LLC, a healthcare company whose mission is to detect cancer early when it can be cured, today announced results from a retrospective analysis of the interventional PATHFINDER study to assess whether diagnostic evaluations of individuals who...

at 14:15
Gracell Biotechnologies Inc. ("Gracell" or the...

at 14:15
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the first-ever results from the Phase 1b RedirecTT-1 study of TECVAYLI® (teclistamab-cqyv), a first-in-class BCMAxCD3 bispecific antibody, and talquetamab, a first-in-class...

at 13:35
Gilead Sciences, Inc. and Arcus Biosciences, Inc. today announced updated results from an interim analysis of the ARC-7 study in patients with first-line, metastatic non-small cell lung cancer (NSCLC) with PD-L1 tumor proportion score (TPS) ?50%...

at 12:17
Sanctuary Cannabis, a trusted provider of high-quality medical cannabis products, is excited to announce the grand opening of its 19th medical cannabis dispensary in Boynton Beach, Florida....

at 12:00
?  PRGN-2009 combined with an investigational checkpoint inhibitor resulted in a 30% ORR in patients with heavily pre-treated HPV-associated cancers that were naïve or resistant to checkpoint blockade with prolonged duration of responses?? ? ...



News published on and distributed by: